Increased intracellular doxorubicin by anti-FAS monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/11337314

Download in:

View as

General Info

PMID
11337314